Artesunate,Mefloquine Hcl. - søkeresultat

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

riamet tablets

novartis pharmaceuticals uk ltd - lumefantrine; artemether - oral tablet - 120mg ; 20mg

USA - engelsk - NLM (National Library of Medicine)

malarone- atovaquone and proguanil hydrochloride tablet, film coated

a-s medication solutions - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt), proguanil hydrochloride (unii: r71y86m0wt) (proguanil - unii:s61k3p7b2v) - malarone® is indicated for the prophylaxis of plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. malarone is indicated for the treatment of acute, uncomplicated p. falciparum malaria. malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance. malarone is contraindicated in individuals with known hypersensitivity reactions (e.g., anaphylaxis, erythema multiforme or stevens-johnson syndrome, angioedema, vasculitis) to atovaquone or proguanil hydrochloride or any component of the formulation. malarone is contraindicated for prophylaxis of p. falciparum malaria in patients with severe renal impairment (creatinine clearance <30 ml/min) because of pancytopenia in patients with severe renal impairment treated with proguanil [see use in specific populations (8.6), clinical pharmacology (12.3)] . pregnancy category c atovaquone atovaqu